載入...
The incidence of tuberculosis in patients treated with certolizumab pegol across indications: impact of baseline skin test results, more stringent screening criteria and geographic region
OBJECTIVES: We report the incidence of tuberculosis (TB) across certolizumab pegol (CZP) clinical trials in rheumatoid arthritis (RA), psoriasis, psoriatic arthritis (PsA) and axial spondyloarthritis (axSpA), before and after the introduction of stricter TB screening. METHODS: TB incidence rates (IR...
Na minha lista:
發表在: | RMD Open |
---|---|
Main Authors: | , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
BMJ Publishing Group
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4613160/ https://ncbi.nlm.nih.gov/pubmed/26509064 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/rmdopen-2014-000044 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|